Capstone Asset Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$375K Sell
9,499
-960
-9% -$37.9K 0.01% 1096
2017
Q1
$424K Sell
10,459
-1,610
-13% -$65.3K 0.01% 1024
2016
Q4
$485K Sell
12,069
-3,430
-22% -$138K 0.01% 956
2016
Q3
$561K Sell
15,499
-160
-1% -$5.79K 0.02% 875
2016
Q2
$454K Buy
15,659
+390
+3% +$11.3K 0.01% 986
2016
Q1
$534K Sell
15,269
-650
-4% -$22.7K 0.02% 887
2015
Q4
$513K Buy
15,919
+100
+0.6% +$3.22K 0.01% 903
2015
Q3
$511K Buy
15,819
+750
+5% +$24.2K 0.02% 904
2015
Q2
$623K Sell
15,069
-7,910
-34% -$327K 0.02% 812
2015
Q1
$1.03M Buy
22,979
+800
+4% +$35.9K 0.03% 649
2014
Q4
$830K Sell
22,179
-2,700
-11% -$101K 0.02% 730
2014
Q3
$869K Sell
24,879
-40
-0.2% -$1.4K 0.03% 650
2014
Q2
$879K Buy
24,919
+3,261
+15% +$115K 0.03% 679
2014
Q1
$706K Sell
21,658
-1,050
-5% -$34.2K 0.02% 805
2013
Q4
$957K Sell
22,708
-5,871
-21% -$247K 0.03% 669
2013
Q3
$1.14M Buy
28,579
+710
+3% +$28.3K 0.03% 688
2013
Q2
$1.15M Buy
+27,869
New +$1.15M 0.03% 635